Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation

Aim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III crit...

Full description

Saved in:
Bibliographic Details
Main Author: O. V. Krapivnaya
Format: Article
Language:Russian
Published: Gastro LLC 2014-07-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1086
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860237405257728
author O. V. Krapivnaya
author_facet O. V. Krapivnaya
author_sort O. V. Krapivnaya
collection DOAJ
description Aim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III criteria) were investigated. All patient underwent BFT (mean No of sessions 6,1±0,9) with rating of IBS symptoms, quality of life (by SF-36 questionnaire), parameters of anorectal manometry before the termination of BFT course.Results. According to anorectal manometry data 1-st type defecation dyssynergy (DD) was diagnosed in 28,9% of patients, dysfunction of an external anal sphincter – in 71,1%. BFT was effective in 24 (63%) patients: in 17 (62,9%) with IBS-C and in 7 (63,6%) with IBS-C and 1-st type DD. Frequency of defecations has increased from 1,1±0,1 to 4,9±0,3 per week (p<0,001), other IBS symptoms (p<0,01) have decreased. Defecation index (OR 6,5; 95% – CI 1,09–39,3) was significant prognostic factor for BFT efficacy.Conclusions. In 63% of patients with IBS-C BFT was effective. The high defecation index (> 1,2) is significant prognostic factor for BFT efficacy.
format Article
id doaj-art-db226cb14a614329a36cfc0fde428e38
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2014-07-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-db226cb14a614329a36cfc0fde428e382025-02-10T16:14:33ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732014-07-012411620687Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipationO. V. Krapivnaya0Non-government healthcare institution «Khabarovsk-1 Road clinical hospital, Open Society «Russian RailwaysAim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III criteria) were investigated. All patient underwent BFT (mean No of sessions 6,1±0,9) with rating of IBS symptoms, quality of life (by SF-36 questionnaire), parameters of anorectal manometry before the termination of BFT course.Results. According to anorectal manometry data 1-st type defecation dyssynergy (DD) was diagnosed in 28,9% of patients, dysfunction of an external anal sphincter – in 71,1%. BFT was effective in 24 (63%) patients: in 17 (62,9%) with IBS-C and in 7 (63,6%) with IBS-C and 1-st type DD. Frequency of defecations has increased from 1,1±0,1 to 4,9±0,3 per week (p<0,001), other IBS symptoms (p<0,01) have decreased. Defecation index (OR 6,5; 95% – CI 1,09–39,3) was significant prognostic factor for BFT efficacy.Conclusions. In 63% of patients with IBS-C BFT was effective. The high defecation index (> 1,2) is significant prognostic factor for BFT efficacy.https://www.gastro-j.ru/jour/article/view/1086irritable bowel syndromebiofeedbacktherapyanorectal manometry
spellingShingle O. V. Krapivnaya
Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
irritable bowel syndrome
biofeedbacktherapy
anorectal manometry
title Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
title_full Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
title_fullStr Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
title_full_unstemmed Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
title_short Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
title_sort effect of biofeedback therapy on clinical semiology quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
topic irritable bowel syndrome
biofeedbacktherapy
anorectal manometry
url https://www.gastro-j.ru/jour/article/view/1086
work_keys_str_mv AT ovkrapivnaya effectofbiofeedbacktherapyonclinicalsemiologyqualityoflifeandsensorimotorfunctionofanorectalareaatirritablebowelsyndromewithrefractoryconstipation